SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Sangamo Biosciences Inc. (SGMO)

SGMO RSS Feed
Add SGMO Price Alert      Hide Sticky   Hide Intro
Moderator: TREND1, Triple9
Search This Board: 
Last Post: 11/26/2017 4:47:05 PM - Followers: 63 - Board type: Free - Posts Today: 0

http://www.sangamo.com/index.php

http://finance.yahoo.com/q/ks?s=SGMO+Key+Statistics

Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company?s proprietary zinc finger DNA-binding protein (ZFP) technology enables specific genome editing and gene regulation. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off. Its therapeutic products include SB-728-T, a ZFN-mediated autologous T-cell product for human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS), which is in Phase II and Phase I clinical trials; and SB-728-HSPC that is in Phase I/II clinical trials for HIV/AIDS. The company also engages in Phase I/II studies of in vivo genome editing applications of ZFP Therapeutics for hemophilia B, Hemophilia A, and Mucopolysaccharidosis I (MPS) and MPS II, which are lysosomal storage disorder (LSD); proprietary preclinical programs in other LSDs; and research stage programs in certain central nervous system disorders and cancer immunotherapies. It has collaborative partnerships with Biogen Inc. to develop therapeutic genome editing products in hemoglobinopathies; and with Shire International GmbH to develop the preclinical development program in Huntington?s disease, as well as license agreement with Sigma-Aldrich Corporation to develop ZFP-based laboratory research reagents and Dow AgroSciences, LLC to modify the genomes or alter protein expression of plant cells, plants, or plant cell cultures. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was founded in 1995 and is headquartered in Richmond, California.

 

SureTrader
Interactive Brokers Advertisement
SGMO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGMO News: Current Report Filing (8-k) 12/14/2017 04:17:43 PM
SGMO News: Statement of Changes in Beneficial Ownership (4) 12/12/2017 06:09:40 PM
SGMO News: Statement of Changes in Beneficial Ownership (4) 12/08/2017 06:54:10 PM
SGMO News: Sangamo Announces European Medicines Agency Recommendation Of Orphan Medicinal Product Designation For Investigational Genome... 12/07/2017 04:22:00 PM
SGMO News: Securities Registration: Employee Benefit Plan (s-8) 11/30/2017 04:19:02 PM
News News Alert: Current Report Filing (8-k) 12/14/2017 04:17:43 PM
PostSubject
#304  Sticky Note SGMO CCI 10 STO 5,1 TREND1 11/23/17 01:57:35 PM
#285  Sticky Note With today's news, $SGMO has 6 approved Phase Triple9 10/02/17 09:16:05 AM
#309   https://www.streetinsider.com/dr/news.php?id=13534330&gfv=1 $20.00 target ofthegreenes 11/26/17 04:47:05 PM
#308   If just started to follow it. TREND1 11/24/17 10:16:30 AM
#307   Do you like this stock? ofthegreenes 11/24/17 07:35:49 AM
#306   Earnings Per Share (EPS) =-1.02 TREND1 11/23/17 02:00:11 PM
#305   Profit/Loss = $ -71.66M TREND1 11/23/17 01:59:29 PM
#304   SGMO CCI 10 STO 5,1 TREND1 11/23/17 01:57:35 PM
#303   Third Quarter 2017 Financial Results TREND1 11/23/17 01:49:20 PM
#302   Indeed it is!!!! hentied 11/15/17 06:41:06 PM
#301   Indeed it is!!!! hentied 11/15/17 06:41:00 PM
#300   This is HUGE for both patients and the company! ByMorStock 11/15/17 05:53:58 PM
#299   Sgmo* not sanp Imfranko 10/26/17 08:38:01 AM
#298   Sanp along side another huge upside play frlf Imfranko 10/26/17 08:37:41 AM
#297   BioSciences logoSangamo BioSciences Inc. (NASDAQ:SGMO) was the recipient ofthegreenes 10/26/17 08:08:55 AM
#296   https://sheridandaily.com/the-street-expecting-0-23-per-share-for-sangamo-therap ofthegreenes 10/25/17 10:55:10 AM
#295   $SGMO is currently rated a HOLD and long Triple9 10/24/17 12:55:37 PM
#294   Is this accurate? I cannot seem to find ofthegreenes 10/23/17 09:35:10 PM
#293   Good sign today. Day before earnings. ofthegreenes 10/23/17 02:14:55 PM
#292   https://www.truebluetribune.com/2017/10/20/bank-of-new-york-mellon-corp-has-2-99 ofthegreenes 10/20/17 09:01:40 AM
#291   I added yesterday, and many other occasions during hentied 10/20/17 06:33:27 AM
#290   Way over sold at this time. Even with ofthegreenes 10/19/17 07:12:32 PM
#289   $SGMO Q3 earnings will be announce on October 24th. Triple9 10/16/17 03:13:28 PM
#288   Sangamo Therapeutics is involved in the quickly growing ByMorStock 10/16/17 07:46:04 AM
#287   Go $SGMO! 100K+ shares purchased at 10:39 Triple9 10/02/17 10:44:21 AM
#286   This was the cover story on Barron's two Triple9 10/02/17 09:20:18 AM
#285   With today's news, $SGMO has 6 approved Phase Triple9 10/02/17 09:16:05 AM
#284   RICHMOND, Calif. and WALTHAM, Mass., Oct. 2, 2017 Triple9 10/02/17 09:07:35 AM
#283   8 Stocks for the Next Gene Revolution ByMorStock 10/02/17 07:41:13 AM
#282   BarChart showing $SGMO as a 96% Strong Buy Triple9 09/29/17 11:22:21 AM
#281   $SGMO hitting the investor circuits hard, first Cantor Triple9 09/29/17 09:19:33 AM
#280   $SGMO presenting to the Cantor Fitzgerald Global Healthcare Triple9 09/27/17 12:05:52 PM
#279   For Hemophilia A, $SGMO has a partnership with $PFE: Triple9 09/27/17 12:02:33 PM
#278   Three current FDA Phase 1/2 trials, for $SGMO: Triple9 09/27/17 12:00:37 PM
#277   $SGMO is pre-clinical with 3 current Phase 1/2 Triple9 09/27/17 11:56:45 AM
#276   SGMO RECEIVES PATENT 9771403 FOR HEMOPHILIA ByMorStock 09/26/17 08:41:49 AM
#275   Adage Capital Partners GP LLC has filed a wiltonio 06/02/17 04:11:34 PM
#274   SGMO buy option 7.47 stocktrademan 05/22/17 03:47:31 PM
#273   * * $SGMO Video Chart 05-12-17 * * ClayTrader 05/12/17 05:12:44 PM
#272   This is probably 6/7 years away from any Jesspro 05/12/17 03:45:38 PM
#271   awesome guys congrats!! moving well on great news. Tdash 05/12/17 11:02:21 AM
#270   Can we see 8 today? no shorts 05/12/17 10:48:21 AM
#269   Great volume no shorts 05/11/17 10:17:35 AM
#268   I'm in no shorts 05/11/17 10:00:15 AM
#267   We got $10 easy Oger 05/10/17 09:00:12 PM
#266   SGMO strong price action after hours. Big day tomorrow. INTL 05/10/17 07:39:25 PM
#265   $SGMO - Sangamo teams up with Pfizer to KarinCA 05/10/17 05:24:32 PM
#264   Yup, congrats. We should see 8 tomorrow Discipline15 05/10/17 05:14:18 PM
#263   Huge huge news!! Goes over $10 tomorrow Oger 05/10/17 05:09:14 PM
#262   Loaded the boat, $SGMO is taking off very Discipline15 04/13/17 03:53:35 PM
#261   http://www.webbreakingnews.com/2017/01/14/piermont-capital-management-inc-buys-1 fstmny13 01/13/17 11:41:20 PM
#260   http://www.webbreakingnews.com/2017/01/14/piermont-capital-management-inc-buys-1 fstmny13 01/13/17 11:40:45 PM
PostSubject